|
⚲
|
| Keyboard |
| Krause Kevin Michael
✚
|
|
|---|---|
| CIK # | 0001916925 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001916925] | |
| 4 | [0001916925] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| AN2 Therapeutics Inc | |
| Krause Kevin Michael |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-03-15 | Grant | 30,000 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2024-03-15 | Grant | 60,000 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-01-09 | Sell | 7,417 | $20.14 | 149,378 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-01-09 | Option exercise | 2,417 | $0.42 | 1,015 |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-01-09 | Option exercise | 5,000 | $6.60 | 33,000 |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2024-01-09 | Option exercise | 2,417 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2024-01-09 | Option exercise | 5,000 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-01-02 | Sell | 2,583 | $20.12 | 51,970 |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2024-01-02 | Option exercise | 2,583 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-01-02 | Option exercise | 2,583 | $0.42 | 1,085 |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2023-02-15 | Grant | 62,200 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2022-05-12 | Grant | 66,000 | $0.00 |